Provider groups renew push for legislation to ensure access to 340B Program drugs

With several weeks left in the spring legislative session, several healthcare associations are again calling on lawmakers to consider legislation that would prohibit pharmaceutical manufacturers from interfering with the ability of providers to receive prescription drugs if contracted with the 340B program, which provides discounted drugs to safety-net providers.